Henvendelser til RELIS om nye antikoagulasjonsmidler
HTNT Nguyen - 2020 - duo.uio.no
Bakgrunn All behandling med antikoagulantia bør gjøres etter individuell vurdering av hver
enkelt pasient, særlig for den eldre pasientgruppen. Regionale …
enkelt pasient, særlig for den eldre pasientgruppen. Regionale …
Bruk av direktevirkende orale antikoagulantia hos eldre multidosepasienter-en studie av interaksjoner, fallrelaterte legemidler og antikolinerge legemidler
OM Søbakk - 2023 - duo.uio.no
Introduksjon Direktevirkende orale antikoagulantia (DOAK) ble tilgjengelige på det norske
markedet i 2012. De fire legemidlene dabigatran, rivaroksaban, apiksaban og edoksaban …
markedet i 2012. De fire legemidlene dabigatran, rivaroksaban, apiksaban og edoksaban …
Prescribing practices and patient perception of anticoagulant treatment in the older population
K Kirkop - 2022 - um.edu.mt
Direct acting oral anticoagulants (DOACs) are a class of oral anticoagulants designed to be
a more tolerated alternative to warfarin. The main patient group of DOACs are older patients …
a more tolerated alternative to warfarin. The main patient group of DOACs are older patients …
Implementation of a standardised annual anticoagulation specialist review in primary care
NW Hutchinson-Jones, SK Didcott… - Primary Health Care …, 2020 - cambridge.org
An increasing number of patients are being prescribed direct oral anticoagulants (DOACs),
while the patients who remain on warfarin are becoming more complex. There is currently a …
while the patients who remain on warfarin are becoming more complex. There is currently a …
The role of anticoagulation clinics needs to be reassessed to include follow up of patients on direct oral anticoagulants
A Tripodi, V Chantarangkul, D Poli, S Testa… - Thrombosis …, 2023 - Elsevier
A survey was carried out to assess the state of organization of care (including clinical and
laboratory) delivered to patients on vitamin K antagonists (VKA) or direct oral anticoagulants …
laboratory) delivered to patients on vitamin K antagonists (VKA) or direct oral anticoagulants …
Evaluation of direct oral anticoagulants (DOACs) prescriptions in geriatric hospital over 3 years
E Nahornyj, S Goutelle, L Bourguignon, B de la Gastine - Therapie, 2020 - europepmc.org
Results A total of 399 patients were included, including 10 in 2015, 110 in 2016 and 279 in
2017. The average age was 85 years old, 40% of patients had a weight of less than 60kg …
2017. The average age was 85 years old, 40% of patients had a weight of less than 60kg …
Influence of stroke and bleeding risk on prescribing of oral anticoagulants in older inpatients; has the availability of direct oral anticoagulants changed prescribing?
N Farinola, GE Caughey, JS Bell… - … Advances in Drug …, 2018 - journals.sagepub.com
Background Little is known about changes in prescribing practices in Australia since the
introduction of the direct oral anticoagulants (DOACs). Our objective was to examine if the …
introduction of the direct oral anticoagulants (DOACs). Our objective was to examine if the …
Bruk av perorale antikoagulantia og legemiddelrelaterte problemer knyttet til dette blant pasienter ved Oslo universitetssykehus, Ullevål
A Fjørkenstad - 2015 - duo.uio.no
Hensikt: Hensikten med denne studien var å kartlegge bruken av perorale antikoagulantia,
samt identifisere og håndtere legemiddelrelaterte problemer (LRP) knyttet til behandlingen …
samt identifisere og håndtere legemiddelrelaterte problemer (LRP) knyttet til behandlingen …
Prospective study of the new oral anticoagulants in private practice: cautious optimism
C Krieger, D Stephan, B Aleil - Annales de cardiologie et d' …, 2015 - europepmc.org
Background The new direct oral anticoagulants (DOA) such as dabigatran, rivaroxaban or
apixaban are an evolution in the management of patients requiring curative anticoagulation …
apixaban are an evolution in the management of patients requiring curative anticoagulation …
[HTML][HTML] Prescribing trends of oral anticoagulants in England over the last decade: a focus on new and old drugs and adverse events reporting
Direct-acting oral anticoagulants (DOACs) are replacing conventional VKA (vitamin K
antagonist, ie, warfarin) for various indications where a therapeutic anticoagulant effect is …
antagonist, ie, warfarin) for various indications where a therapeutic anticoagulant effect is …